References

1. 1.
   MAOMAO C，HE L，DIANQIN S，et al.Current cancer burden in China：Epidemiology，etiology，and prevention［J］.Cancer Biol Med，2022，19（8）：1121-1138.
2. 2.
   MCGLYNN K A，PETRICK J L，GROOPMAN J D.Liver cancer：Progress and priorities［J］.Cancer Epidemiol Biomarkers Prev，2024，33（10）：1261-1272.
3. 3.
   HUANG P S，WANG L Y，WANG Y W，et al.Evaluation and application of drug resistance by biomarkers in the clinical treatment of liver cancer［J］.Cells，2023，12（6）：869.
4. 4.
   XUE Y，RUAN Y，WANG Y，et al.Signaling pathways in liver cancer：Pathogenesis and targeted therapy［J］.Mol Biomed，2024，5（1）：20.
5. 5.
   XU X Y，ZHU Y P，LIU Y Q，et al.Mechanism of treatment of hepatocellular carcinoma with traditional Chinese medicine based on epigenetic regulation：A review ［J］.Chin J Exp Tradit Med Form，2024，30（23）：281-291.
6. 6.
   MA Y N，JIANG X，TANG W，et al.Influence of intermittent fasting on autophagy in the liver［J］.Biosci Trends，2023，17（5）：335-355.
7. 7.
   XIANG H，ZHANG J，LIN C，et al.Targeting autophagy-related protein kinases for potential therapeutic purpose［J］.Acta Pharm Sin B，2020，10（4）：569-581.
8. 8.
   PENUGURTI V，MISHRA Y G，MANAVATHI B.AMPK：An odyssey of a metabolic regulator，a tumor suppressor，and now a contextual oncogene［J］.Biochim Biophys Acta Rev Cancer，2022，1877（5）：188785.
9. 9.
   KHALIL M I，ALI M M，HOLAIL J，et al.Growth or death？ Control of cell destiny by mTOR and autophagy pathways［J］.Prog Biophys Mol Biol，2023，185：39-55.
10. 10.
    MOSSMANN D，PARK S，HALL M N.mTOR signalling and cellular metabolism are mutual determinants in cancer［J］.Nat Rev Cancer，2018，18（12）：744-757.
11. 11.
    GE Y，ZHOU M，CHEN C，et al.Role of AMPK mediated pathways in autophagy and aging［J］.Biochimie，2022，195：100-113.
12. 12.
    MENG S S，GU H W，ZHANG T，et al.Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders，cellular aging，and chronic inflammation［J］.Front Oncol，2023，13：1099624.
13. 13.
    CUI J，SHEN H M，LIM L H K.The role of autophagy in liver cancer：Crosstalk in signaling pathways and potential therapeutic targets［J］.Pharmaceuticals （Basel），2020，13（12）：432.
14. 14.
    LIU G，KUANG S，CAO R，et al.Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway［J］.Faseb j，2019，33（9）：10089-10103.
15. 15.
    HERNANDEZ G A，PERERA R M.Autophagy in cancer cell remodeling and quality control［J］.Mol Cell，2022，82（8）：1514-1527.
16. 16.
    MILLER D R，THORBURN A.Autophagy and organelle homeostasis in cancer［J］.Dev Cell，2021，56（7）：906-918.
17. 17.
    CHAO X，QIAN H，WANG S，et al.Autophagy and liver cancer［J］.Clin Mol Hepatol，2020，26（4）：606-617.
18. 18.
    RAHMAN M A，RAKIB-UZ-ZAMAN S M，CHAKRABORTI S，et al.Advancements in utilizing natural compounds for modulating autophagy in liver cancer：Molecular mechanisms and therapeutic targets［J］.Cells，2024，13（14）：1186.
19. 19.
    CAO W，LI J，YANG K，et al.An overview of autophagy：Mechanism，regulation and research progress［J］.Bull Cancer，2021，108（3）：304-322.
20. 20.
    WANG H，LIU Y，WANG D，et al.The upstream pathway of mTOR-mediated autophagy in liver diseases［J］.Cells，2019，8（12）：1597.
21. 21.
    WANG Z，SHEN J，CHEN C，et al.FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance［J］.Biosci Trends，2023，17（2）：136-147.
22. 22.
    KASHYAP D，GARG V K，GOEL N.Intrinsic and extrinsic pathways of apoptosis：Role in cancer development and prognosis［J］.Adv Protein Chem Struct Biol，2021，125：73-120.
23. 23.
    BORAEI A T A，ELTAMANY E H，ALI I A I，et al.Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction：In vitro，in vivo，and in silico integrated approaches［J］.Bioorg Chem，2021，111：104877.
24. 24.
    CARNEIRO B A，EL-DEIRY W S.Targeting apoptosis in cancer therapy［J］.Nat Rev Clin Oncol，2020，17（7）：395-417.
25. 25.
    XIE G，SUN L，LI Y，et al.Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling［J］.Cancer Med，2021，10（1）：325-336.
26. 26.
    ZHENG Y，WANG K，WU C，et al.COTI-2 suppresses the malignancy of bladder cancer by inducing apoptosis via the AMPK-mTOR signaling pathway［J］.Iran J Basic Med Sci，2025，28（3）：240-246.
27. 27.
    LIU X，HU X，KUANG Y，et al.BCLB，methylated in hepatocellular carcinoma is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade［J］.Cancer Lett，2017，395：63-71.
28. 28.
    VAN NOORDEN C J F，YETKIN-ARIK B，SERRANO MARTINEZ P，et al.New insights in ATP synthesis as therapeutic target in cancer and angiogenic ocular diseases［J］.J Histochem Cytochem，2024，72（5）：329-352.
29. 29.
    FENG J，LI J，WU L，et al.Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma［J］.J Exp Clin Cancer Res，2020，39（1）：126.
30. 30.
    DU D，LIU C，QIN M，et al.Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma［J］.Acta Pharm Sin B，2022，12（2）：558-580.
31. 31.
    WANG B，PU R.Association between glycolysis markers and prognosis of liver cancer：A systematic review and Meta-analysis［J］.World J Surg Oncol，2023，21（1）：390.
32. 32.
    BOUROUH M，MARIGNANI P A.The tumor suppressor kinase LKB1：Metabolic nexus［J］.Front Cell Dev Biol，2022，10：881297.
33. 33.
    ZEB A，KHAN W，UL ISLAM W ，et al.Exploring the anticancer potential of astragalin in triple negative breast cancer cells by attenuating glycolytic pathway through AMPK/mTOR［J］.Curr Med Chem，2024，doi：.
34. 34.
    FANG G，ZHANG P，LIU J，et al.Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling［J］.Cancer Lett，2019，463：11-26.
35. 35.
    YE H，LIU Y，WU K，et al.AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer［J］.Cell Commun Signal，2020，18（1）：115.
36. 36.
    ZHANG H，YU J，MA L，et al.Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy［J］.Int J Pharm，2022，624：121931.
37. 37.
    LI J，WU P W，ZHOU Y，et al.Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy［J］.Cell Death Dis，2018，9（2）：225.
38. 38.
    REYES R，WANI N A，GHOSHAL K，et al.Sorafenib and 2-deoxyglucose synergistically inhibit proliferation of both sorafenib-sensitive and -resistant HCC cells by inhibiting ATP production［J］.Gene Expr，2017，17（2）：129-140.
39. 39.
    CHEKI M，MOSTAFAEI S，HANAFI M G，et al.Radioproteomics modeling of metformin-enhanced radiosensitivity：An animal study［J］.Jpn J Radiol，2023，41（11）：1265-1274.
40. 40.
    KIM E H，KIM M S，FURUSAWA Y，et al.Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams［J］.Oncotarget，2016，7（49）：80568-80578.
41. 41.
    BATTAGLIA A M，CHIRILLO R，AVERSA I，et al.Ferroptosis and cancer：Mitochondria meet the "iron maiden" cell death［J］.Cells，2020，9（6）：1505.
42. 42.
    TONG X，TANG R，XIAO M，et al.Targeting cell death pathways for cancer therapy：Recent developments in necroptosis，pyroptosis，ferroptosis，and cuproptosis research［J］.J Hematol Oncol，2022，15（1）：174.
43. 43.
    ZHANG B，ZHAO J，LIU B，et al.Development and validation of a novel ferroptosis-related gene signature for prognosis and immunotherapy in hepatocellular carcinoma［J］.Front Mol Biosci，2022，doi：.
44. 44.
    HAN D，JIANG L，GU X，et al.SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels［J］.J Cell Physiol，2020，235（11）：8839-8851.
45. 45.
    SUN Z，LIU L，LIANG H，et al.Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma［J］.Mol Carcinog，2024，63（4）：577-588.
46. 46.
    HUANG Y，HONG W，WEI X.The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis［J］.J Hematol Oncol，2022，15（1）：129.
47. 47.
    LI Z，LIU B，LI C，et al.NRBP2 functions as a tumor suppressor and inhibits epithelial-to-mesenchymal transition in breast cancer［J］.Front Oncol，2021，11：634026.
48. 48.
    QUE T，REN B，FAN Y，et al.Capsaicin inhibits the migration，invasion and EMT of renal cancer cells by inducing AMPK/mTOR-mediated autophagy［J］.Chem Biol Interact，2022，366：110043.
49. 49.
    SUN Y，LEI B，HUANG Q.SOX18 affects cell viability，migration，invasiveness，and apoptosis in hepatocellular carcinoma （HCC） cells by participating in epithelial-to-mesenchymal transition （EMT） progression and adenosine monophosphate activated protein kinase （AMPK）/mammalian target of rapamycin （mTOR）［J］.Med Sci Monit，2019，25：6244-6254.
50. 50.
    HEAD S A，SHI W Q，YANG E J，et al.Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of mTOR signaling and angiogenesis［J］.ACS Chem Biol，2017，12（1）：174-182.
51. 51.
    FU C，AN N，LIU J，et al.The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells［J］.J Biol Chem，2020，295（20）：7060-7074.
52. 52.
    WEI H，XU Z，CHEN L，et al.Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling［J］.Cell Death Dis，2022，13（2）：102.
53. 53.
    JIANG D，QI Z，XU Z Y，et al.F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway［J］.Biomol Biomed，2024，25（1）：189-209.
54. 54.
    LEI H W，CAI J，LI C M，et al.Rapamycin combined with TAE on the growth，metastasis，and prognosis of hepatocellular carcinoma in rat models［J］.Ann Hepatol，2018，17（4）：645-654.
55. 55.
    PAKRAVAN K，BABASHAH S，SADEGHIZADEH M，et al.MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells［J］.Cell Oncol （Dordr），2017，40（5）：457-470.
56. 56.
    LI Y，SUN R，ZOU J，et al.Dual roles of the AMP-activated protein kinase pathway in angiogenesis［J］.Cells，2019，8（7）：752.
57. 57.
    WEI T，CHENG J，JI Y，et al.Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/Akt/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma［J］.Open Life Sci，2024，19（1）：20220914.
58. 58.
    KIM S M，HA S E，LEE H J，et al.Sinensetin induces autophagic cell death through p53-Related AMPK/mTOR signaling in hepatocellular carcinoma HepG2 cells［J］.Nutrients，2020，12（8）：2462.
59. 59.
    YIN X，LI W，ZHANG J，et al.AMPK-mediated metabolic switching is high effective for phytochemical levo-tetrahydropalmatine （l-THP） to reduce hepatocellular carcinoma tumor growth［J］.Metabolites，2021，11（12）：811.
60. 60.
    HAN B，YU Y Q，YANG Q L，et al.Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling［J］.Oncotarget，2017，8（49）：86227-86239.
61. 61.
    ZHANG H，SU X，GU L，et al.Colchicine-mediated selective autophagic degradation of HBV core proteins inhibits HBV replication and HBV-related hepatocellular carcinoma progression［J］.Cell Death Discov，2024，10（1）：352.
62. 62.
    FAN H，JI Y，WANG Y，et al.Anthocyanins from Lycium ruthenicum murray inhibit HepG2 cells growth，metastasis and promote apoptosis and G₂/M phase cycle arrest by activating the AMPK/mTOR autophagy pathway［J］.Evid Based Complement Alternat Med，2022，2022：9609596.
63. 63.
    CHEN Y L，YEN I C，LIN K T，et al.4-Acetylantrocamol LT3，a new ubiquinone from Antrodia cinnamomea，inhibits hepatocellular carcinoma HepG2 cell growth by targeting YAP/TAZ，mTOR，and Wnt/β-catenin signaling［J］.Am J Chin Med，2020，48（5）：1243-1261.
64. 64.
    EL-SEWEDY T，SALAMA A F，MOHAMED A E，et al.Hepatocellular carcinoma cells：Activity of amygdalin and sorafenib in targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death［J］.BMC Complement Med Ther，2023，23（1）：329.
65. 65.
    AL-ZAHRANI N S，ZAMZAMI M A，BAGHDADI M A，et al.Regulation of protein-induced apoptosis and autophagy in human hepatocytes treated with metformin and paclitaxel in silico and in vitro［J］.Biomedicines，2023，11（10）：2688.
66. 66.
    YU H，HAO Z，LIU X，et al.Autophagy blockage and lysosomal dysfunction are involved in diallyl sulfide-induced inhibition of malignant growth in hepatocellular carcinoma cells［J］.Environ Toxicol，2023，38（9）：2100-2110.
67. 67.
    SHUI L，WANG W，XIE M，et al.Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway［J］.Aging （Albany NY），2020，12（23）：24318-24332.
68. 68.
    KWON H Y，KIM J H，KIM B，et al.Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells［J］.Arch Toxicol，2018，92（1）：241-257.
69. 69.
    LEE Y G，JANG S A，SONG H S，et al.Bakuchiol from Cullen corylifolium and its efficacy on apoptosis and autophagy in HepG2 cells［J］.Heliyon，2024，10（23）：e40758.
70. 70.
    WU H，QU L，BAI X，et al.Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway［J］.Food Chem Toxicol，2024，186：114587.
71. 71.
    CUI Y Q，LIU Y J，ZHANG F.The suppressive effects of Britannin （Bri） on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS［J］.Biochem Biophys Res Commun，2018，497（3）：916-923.
72. 72.
    WANG P，ZHANG S D，JIAO J，et al.ROS-mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro［J］.Toxicol Appl Pharmacol，2019，379：114647.
73. 73.
    VISHNOI K，KE R，SAINI K S，et al.Berberine represses β-catenin translation involving 4E-BPs in hepatocellular carcinoma cells［J］.Mol Pharmacol，2021，99（1）：1-16.
74. 74.
    HAN M，GAO H，XIE J，et al.Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway［J］.Acta Pharmacol Sin，2019，40（5）：666-676.
75. 75.
    CHO A R，PARK W Y，LEE H J，et al.Antitumor effect of morusin via g1 arrest and antiglycolysis by AMPK activation in hepatocellular cancer［J］.Int J Mol Sci，2021，22（19）：10619.
76. 76.
    HUANG H，XUE J，XIE M L，et al.Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice［J］.Strahlenther Onkol，2024，200（5）：444-452.
77. 77.
    ZHANG R，WANG N，FAN B，et al.Potentiation of sorafenib's action by berberine via suppression of the mTOR signaling pathway in human hepatoma cells［J］.Nutr Cancer，2025，77（4/5）：553-565.
78. 78.
    WANG B，MIN W，LIN S，et al.Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation［J］.Int J Med Sci，2021，18（6）：1465-1473.
79. 79.
    HE L W，LIN C J，ZHUANG L J，et al.Targeting hepatocellular carcinoma：Schisandrin a triggers mitochondrial disruption and ferroptosis［J］.Chem Biol Drug Des，2024，104（6）：e70010.
80. 80.
    YANG X，XIE J，LIU X，et al.Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma［J］.Cell Biochem Funct，2019，37（3）：128-138.
81. 81.
    KIM Y W，JANG E J，KIM C H，et al.Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells［J］.Chem Biol Interact，2017，261：108-117.